Chronic refractory cough patients have persistent, unexplained, treatment-resistant symptoms. Very little is known about non-physiological processes underlying chronic refractory cough or patients’ experience of the condition. In all, 14 patients participated in semi-structured interviews. Interviews were based on the comprehensive cognitive behavioural model and analysed thematically. Eight key themes emerged illustrating that the experience of the onset and persistence of chronic refractory cough is complex, often involving multiple interlinking factors. Themes highlighted the involvement of biological and psychological factors, and the prominent role of the social dimension in how the cough is experienced, perceived and managed. Implications for intervention development are discussed.
AbdulqawiRDockryRHoltKet al. (2015) P2X3 receptor antagonist (AF219) in refractory chronic cough: A randomised, double blind, placebo-controlled phase 2 study. The Lancet385(9974): 1198–1205.
2.
AndoASmallwoodDMcMahonMet al. (2016) Neural correlates of cough hypersensitivity in humans: Evidence for central sensitisation and dysfunctional inhibitory control. Thorax71(4): 323–339.
3.
BirringSS (2011) Controversies in the evaluation and management of chronic cough. American Journal of Respiratory and Critical Care Medicine183: 708–715.
4.
BirringSSPrudonBCarrAJet al. (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Cough5: 339–343.
5.
BraunVClarkV (2006) Using thematic analysis in psychology. Qualitative Research in Psychology3: 77–101.
6.
BrignallKJayaramanBBirringSS (2008) Quality of life and psychosocial aspects of cough. Lung186(1): 55–58.
7.
BurtonCLucassenPAamlandAet al. (2015) Explaining symptoms after negative tests: Towards a rational explanation. Journal of the Royal Society of Medicine108(3): 84–88.
8.
ChamberlainSAFBirringSSClarkeLet al. (2014) Efficacy of a physiotherapy, speech and language therapy intervention (PSALTI) on health related quality of life (HRQol) for patients with refractory chronic cough: A randomised control trial [abstract]. Thorax69: A78.
9.
ChungKF (2014) Approach to chronic cough: The neuropathic basis for cough hypersensitivity syndrome. Journal of Thoracic Disease6(7): 699–707.
10.
ChungKFPavordID (2008) Prevalence, pathogenesis, and causes of chronic cough. The Lancet371: 1364–1374.
11.
CraigPDieppePMacintyreSet al. (2008) Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ33: a1655.
12.
DavenportPWVovkADukeRKet al. (2009) The urge-to-cough and cough motor response modulation by the central effects of nicotine. Pulmonary Pharmacology and Therapeutics22(2): 82-89.
13.
DearyVChalderTSharpeM (2007) The cognitive behavioural model of medically unexplained symptoms: A theoretical and empirical review. Clinical Psychology Review27: 781–797.
14.
DicpinigaitisPVTsoRBanauchG (2006) Prevalence of depressive symptoms among patients with chronic cough. Chest130(6): 1839–1843.
15.
HaqueRAUsmaniOSBarnesPJ (2005) Chronic idiopathic cough. A discrete clinical entity?Chest127(5): 1710–1713.
16.
HeglandKWBolserDCDavenportPW (2012) Volitional control of reflex cough. Journal of Applied Physiology113: 39–46.
17.
HiltonEMarsdenPThurstonAet al. (2015) Clinical features of urge-to-cough in patients with chronic cough. Respiratory Medicine109(6): 701–707.
18.
HutchingsHAEcclesRSmithAPet al. (1993) Voluntary cough suppression as an indication of symptom severity in upper respiratory tract infections. European Respiratory Journal6: 1449–1454.
19.
JacobyASnapeDBakerG (2005) Epilepsy and social identity: The stigma of a chronic neurological disorder. The Lancet4(3): 171–178.
20.
JanssensTBrepoelsSDupontet al. (2015) The impact of harmfulness information on citric acid induced cough and urge-to-cough. Pulmonary Pharmacology & Therapeutics31: 9–14.
21.
JanssensTSilvaMDavenportPWet al. (2014) Attentional modulation of reflex cough. Chest146(1): 135–141.
22.
McGarveyLPACartonCGambleLAet al. (2006) Prevalence of psychomorbidity among patients with chronic cough. Cough2: 4–5.
23.
McGarveyLPAHeaneyLGLawsonJTet al. (1998) Evaluation and outcome of patients with chronic non-productive cough using a diagnostic protocol. Thorax53(9): 738–743.
MoriceAHMenonMSMulrennanSAet al. (2007) Opiate therapy in chronic cough. American Journal of Respiratory and Critical Care Medicine175(4): 312–315.
26.
MoriceAHMillqvistEBelvisiMGet al. (2014) Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. European Respiratory Journal44(5): 1132–1148.
27.
O’ConnellFThomasVEPrideNBet al. (1994) Capsaicin cough sensitivity decreases with successful treatment of chronic cough. American Journal of Respiratory and Critical Care Medicine150(2): 374–380.
28.
PatelASWatkinGWilligBet al. (2011) Improvement in health status following cough-suppression physiotherapy for patients with chronic cough. Chronic Respiratory Disease8: 253–258.
29.
PolleyLCardwellCCostelloRet al. (2005) Predictors of idiopathic cough: Outcome of a retrospective analysis. Thorax60: 107.
30.
RyanNMBirringSSGibsonPG (2012) Gabapentin for refractory chronic cough: A randomised, double-blind, placebo-controlled trial. The Lancet380(9853): 1583–1589.
31.
RyanNMVertiganAEBoneSet al. (2010) Cough reflex sensitivity improves with speech and language pathology management of refractory chronic cough. Cough6: 5.
32.
Van den BerghOVan DiestIDupontLet al. (2012) On the psychology of cough. Lung190: 55–61.
33.
VertiganAETheodorosDGGibsonPGet al. (2006) Efficacy of speech pathology management for chronic cough: A randomised placebo control trial of treatment efficacy. Thorax61(12): 1065–1069.
34.
YoungECSmithJA (2010) Quality of life in patients with chronic cough. Therapeutic Advances in Respiratory Disease4: 49–55.
